Eli Lilly 35% A better product does not always mean that it will become more popular
"When treating millions of people with medications like semaglutide, even relatively rare side effects will occur in a large number of people," said Susan Yanovski, MD, senior scientific advisor for clinical obesity research and codirector of the National Institute of Diabetes and Digestive and Kidney Diseases' Office of Obesity Research(3 Trusted Source As Semaglutide's Popularity Soars, Rare but Serious Adverse Effects Are Emerging Go to source)
Manufacturers and pharmacies seem to be trying to justify their continued compounding by adding in extra ingredients like B vitamins so the drugs arent exact copies (In a note, Eli Lilly recently warned about potential impurity risks of compounds that do this)
Reading syringe markings correctly prevents dosing errors
Answer: Good candidates are adults struggling with persistent hunger, a stalled response to GLP-1 medications, insulin resistance, or a long history of weight cycling, who want to address the hormonal driver of appetite rather than rely on restriction alone
While higher doses (1012 mg per week) have been associated with faster fat loss, theyre not always the best option for everyone
